Table 3.
Mixed effects model multiple meta-regression of gluteal, femoral, and visceral adipocyte diameter as a function of subcutaneous adipocyte diameter and sex
| Predictor | Coefficient (β) | Lower bound (95% CI) | Upper bound (95% CI) | P value |
|---|---|---|---|---|
| Dependent variable: gluteal subcutaneous adipocyte diameter (μm) | ||||
| (Intercept) | 22.5476 | 14.9479 | 30.1474 | <.0001 |
| abSC FCS | 0.8129 | 0.7424 | 0.8833 | <.0001 |
| % Women | 1.7878 | –1.9485 | 5.5242 | .3363 |
| Dependent variable: femoral subcutaneous adipocyte diameter (μm) | ||||
| (Intercept) | 13.6637 | –1.7442 | 29.0715 | .0801 |
| abSC FCS | 0.9127 | 0.7639 | 1.0614 | <.0001 |
| % Women | 3.4501 | –0.7970 | 7.6973 | .1074 |
| Dependent variable: visceral subcutaneous adipocyte diameter (μm) | ||||
| (Intercept) | 3.8491 | –4.7361 | 12.4344 | .3747 |
| abSC FCS | 0.9325 | 0.8535 | 1.0114 | <.0001 |
| % Women | –11.2152 | –15.5459 | –6.8845 | <.0001 |
Abbreviations: abSC, abdominal subcutaneous; CI, confidence interval; FCS, fat cell size; % Women, percentage of women.